Validation and implementation of the GeneXpert MRSA/SA blood culture assay in a pediatric setting

American Journal of Clinical Pathology

Volumn 136, Issue 5, 2011, Pages 690-694

  Spencer, David H ^a   Sellenriek, Patricia ^b   Burnham, Carey Ann D ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST LOUIS CHILDREN S HOSPITAL   (United States)

Author keywords

Bacteremia; GeneXpert; Methicillin resistance; MRSA; Staphylococcus aureus

Indexed keywords

ARTICLE; BACTERIAL GENETICS; BLOOD CULTURE; GENETIC SCREENING; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; NONHUMAN; PEDIATRIC HOSPITAL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

BACTERIOLOGICAL TECHNIQUES; CHILD; HUMANS; METHICILLIN RESISTANCE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; POLYMERASE CHAIN REACTION; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 80355126480     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCP07UGYOKBVVNC     Document Type: Article

References (10)

1. Bauer KA, West JE, Balada-Llasat JM, et al. An antimicrobial stewardship program's impact with rapid polymerase chain reaction methicillin-resistant Staphylococcus aureus/S aureus blood culture test in patients with S aureus bacteremia. Clin Infect Dis. 2010;51:1074-1080.
2. Chambers HF, Deleo FR. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol. 2009;7:629-641.
3. Chambers HF. Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Clin Microbiol Rev. 1997;10:781-791. (Pubitemid 27477734)
4. Parta M, Goebel M, Thomas J, et al. Impact of an assay that enables rapid determination of Staphylococcus species and their drug susceptibility on the treatment of patients with positive blood culture results. Infect Control Hosp Epidemiol. 2010;31:1043-1048.
5. Xpert MRSA-SA BC G2 [package insert]. Sunnyvale, CA: Cepheid; 2008.
6. Laurent C, Bogaerts P, Schoevaerdts D, et al. Evaluation of the Xpert MRSA assay for rapid detection of methicillin-resistant Staphylococcus aureus from nares swabs of geriatric hospitalized patients and failure to detect a specific SCCmec type IV variant. Eur J Clin Microbiol Infect Dis. 2010;29:995-1002.
7. Parta M, Goebel M, Matloobi M, et al. Identification of methicillin-resistant or methicillin-susceptible Staphylococcus aureus in blood cultures and wound swabs by GeneXpert. J Clin Microbiol. 2009;47:1609-1610.
8. Wolk DM, Struelens MJ, Pancholi P, et al. Rapid detection of Staphylococcus aureus and methicillin-resistant S aureus (MRSA) in wound specimens and blood cultures: multicenter preclinical evaluation of the Cepheid Xpert MRSA/SA skin and soft tissue and blood culture assays. J Clin Microbiol. 2009;47:823-826.
9. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supplement. Wayne, PA: Clinical and Laboratory Standards Institute; 2010. CLSI document M100-S20.
10. US Food and Drug Administration. Cepheid Xpert MRSA/SA Blood Culture Assay for Use with the GeneXpert Dx System. 2010. http://www.fda.gov/ MedicalDevices/Safety/RecallsCorrectionsRemovals/ListofRecalls/ucm218002.htm. Accessed January 2011.